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Misfolded proinsulin in the endoplasmic reticulum during development of beta cell 
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The endoplasmic reticulum (ER) is broadly distributed throughout the cytoplasm of 
pancreatic beta cells, and this is where all proinsulin is initially made.  Healthy beta cells can 
synthesize 6000 proinsulin molecules per second.  Ordinarily, nascent proinsulin entering the 
ER rapidly folds via the formation of three evolutionarily conserved disulfide bonds (B7–A7, 
B19–A20, and A6–A11).  A modest amount of proinsulin misfolding, including both 
intramolecular disulfide mispairing and intermolecular disulfide-linked protein complexes, is 
a natural by-product of proinsulin biosynthesis, as is the case for many proteins.  The steady-
state level of misfolded proinsulin — a potential ER stressor — is linked to (1) production 
rate, (2) ER environment, (3) presence or absence of naturally occurring (mutational) defects 
in proinsulin, and (4) clearance of misfolded proinsulin molecules.  Accumulation of 
misfolded proinsulin beyond a certain threshold begins to interfere with the normal 
intracellular transport of bystander proinsulin, leading to diminished insulin production and 
hyperglycemia, as well as exacerbating ER stress.  This is most obvious in mutant INS gene–
induced diabetes of youth (MIDY; an autosomal dominant disease) but also likely to occur in 
type 2 diabetes owing to dysregulation in proinsulin synthesis, ER folding environment, or 
clearance.   
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Growing evidence suggests that, during progression of type 2 diabetes, loss of pancreatic beta 
cell function and eventual loss of beta cell mass is accompanied by endoplasmic reticulum 
(ER) stress.
1–4
  Many factors may contribute to ER stress, but one of the most well recognized 
of these factors are conditions that promote misfolding of secretory proteins within the ER 
lumen.
5
  The beta cell secretory proteins most cited as prone to misfolding are islet amyloid 
polypeptide (IAPP) and proinsulin.
6,7
  In rodent models of type 2 diabetes, endogenous IAPP 
does not misfold, and, even in felines, nonhuman primates, and humans, there is little 
convincing data to establish that nascent pro-IAPP is amyloidogenic during its passage 
through the ER compartment.
8
  By contrast, there is a growing body of evidence to suggest 
that proinsulin misfolding may occur in the ER, triggering beta cell ER stress.  As we discuss 
below, proinsulin misfolding in the ER is most readily detected by the presence of mispaired 
disulfide bonds, including both intramolecular and intermolecular disulfide mispairings.   
To date, there has been vastly more study of insulin misfolding (a pharmaceutical 
problem) than proinsulin misfolding (a cell biological problem).
9
  As the C-peptide of 
proinsulin is largely unstructured, the conformational state of proinsulin is dominated by its 
insulin moiety, comprised of the 30-residue B-chain and the 21 residue A-chain.  In the 
insulin crystal structure, the N-terminal B-chain offers a central α helix and the A-chain 
provides two additional short α helices.  Amino acids L(A16), Y(A19), L(B11), L(B15), and 
R(B22) have been reported to be the five most importantly positioned residues in stabilizing 
the folded state of the insulin monomer.
10
  Distinct crystallographic structures known as R 
and T states reflect dynamic differences in amino terminal portion of the B-chain, which can 
be mostly α-helical (R state) or extended (T state).
11
  Like many globular proteins, insulin has 
a number of buried hydrophobic residues in the native state that may become solvent exposed 
in incompletely folded states.
12
  Such improperly exposed peptide sequences, especially those 
including the central B-chain helix LVEALYL, are thought to be aggregation 
prone/amyloidogenic
13
 and can associate with neighboring insulin moieties, even when they 
are in the native state.
14
  In the native state, two of the insulin disulfide bonds––C(A6)–
C(A11) and C(B19)–C(A20)––are no longer exposed to  solvent, and both burying and 
consumption of the C(A11) thiol are particularly important for the proinsulin folding 
pathway.
15
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ER membrane such that the nascent translation product is translocated into the ER lumen, 
followed by cleavage of its signal peptide.
16,17
  Upon entry into the ER lumen, proinsulin 
becomes exposed to an oxidizing environment in which cysteine thiols are highly reactive.
18
  
Proinsulin contains only six cysteine residues,
19
 and, like most members of the insulin 
superfamily, proinsulin forms three evolutionarily conserved native disulfide bonds (Fig. 1), 
including proinsulin Cys(B7)–Cys(A7), Cys(B19)–Cys(A20), and Cys(A6)–Cys(A11).   
The first evidence that things might go wrong in proinsulin disulfide pairing in the ER 
resulted from  Tris–tricine–urea–SDS-PAGE analysis of proinsulin variants bearing 
genetically engineered S(B9)D, H(B10)D, or V(B12)E substitutions: all proinsulin molecules 
migrated similarly under reducing conditions, but a significant subfraction of the variant 
proinsulin molecules migrated as an anomalously shifted (less compact) form under 
nonreducing conditions.
20
  Additionally, it was noted that one contribution of the C-peptide is 
to permit the proinsulin polypeptide chain to fold back on itself, such that genetically 
engineered foreshortening of the C-peptide interfered with the B-chain properly aligning with 
the A-chain for formation of the Cys(B7)–Cys(A7) and Cys(B19)–Cys(A20) disulfide 
bonds.
21
   
In the course of these analyses, the observation emerged that small quantities of 
nonnative proinsulin disulfide isomers were also formed during the synthesis of wild-type 
proinsulin in isolated, normal pancreatic islets,
22
 and the most predominant non-native form 
in these islets showed selectively increased recognition by the ER HSP70 chaperone known 
as BiP (Fig. 2); this nonnative form was recovered at increased levels from islets incubated 
under high-glucose conditions
22
 that promote translatability of the preproinsulin mRNA.
23
  
Thus, production of a small fraction of misfolded proinsulin monomers occurs as a natural 
by-product in the synthesis of native proinsulin.   
Proinsulin dimerizes
24
 within the ER,
25,26
 and this has interesting ramifications in cells 
expressing misfolded proinsulin that remains trapped in this compartment because of ER 
quality control.
27
  Indeed, when expressing a proinsulin that is C-terminally tagged with 
KDEL (to prevent successful anterograde trafficking because of retention/retrieval via KDEL 
receptors), co-expressed untagged proinsulin is retained in trans, whereas some unrelated 
secretory proteins can continue to proceed unimpeded through the secretory pathway.
28
  
These data indicate that an ER-retained proinsulin can transfer the property of being retained 
(i.e., unsuccessful anterograde traffic) to other bystander proinsulin molecules within the ER.   




This article is protected by copyright. All rights reserved. 
5 
 
proinsulin.  Interestingly, this animal expresses three wild-type INS alleles and a fourth allele 
encoding mutant proinsulin-C(A7)Y that is retained in the ER and triggers ER stress.
29,30
  
However, because ER-retained proinsulin can transfer its retention property to bystander 
proinsulin molecules, Akita-proinsulin causes co-retention of endogenous wild-type 
proinsulin.
31
  Curiously, by SDS-PAGE and western blotting, a (GFP-tagged) Akita proinsulin 
was predominantly recovered under nonreducing conditions not as a monomer but as a 
disulfide-linked complex (Fig. 3A, arrows).  Immunoprecipitation of tagged Akita proinsulin 
co-precipitates endogenous (untagged) bystander proinsulin molecules that also become 
engaged in disulfide-linked protein complexes but can be recovered as a monomer upon 
SDS-PAGE under reducing conditions (Fig. 3B).   
Increasing evidence suggests that an abundance of disulfide-linked proinsulin 
aggregates is likely to contribute to beta cell ER stress and diabetes, thereby raising the 
question: What are the factors that promote increased abundance of disulfide-linked 
proinsulin aggregates?  We reason (Fig. 4) that, in the steady state, proinsulin aggregates 
accumulate on the basis of (1) the rate of their formation that is linked to the rate of 
proinsulin synthesis, which is upregulated in states of increased metabolic demand; (2) the 
prevailing ER environment, which may not be homeostatically maintained to provide both 
optimal oxidative capacity and functional helper proteins for proinsulin folding; (3) the 
presence or absence of primary structural defects intrinsic to the proinsulin molecule itself; 
and (4) the disposal (or, conversely, the stability/resistance to disposal) of both misfolded 
proinsulin monomers and aggregates, primarily by ER-associated degradation (ERAD).  Both 
the formation and prevention of accumulation of these aggregates are the subjects of the 
current review.   
 
 
Misfolded proinsulin molecules occur in conjunction with proinsulin synthesis  
In addition to increased proinsulin synthesis observed upon metabolic demand leading to 
increased abundance of misfolded proinsulin monomers,
22
 there is an additional increase of 
proinsulin synthesis if islet beta cells fail to deliver sufficient signaling from one of their 
major ER stress sensors, known as PERK.
32
  PERK is a negative regulator of general 
translation and is highly expressed in islets.  Deficiency of pancreatic PERK-mediated 
phosphorylation of eIF2α, the regulatory subunit (that controls the guanine nucleotide 
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glucose levels but may contribute particularly under prolonged hyperglycemic conditions, in 
which increased ER stress response, including eIF2α phosphorylation, would normally be 
expected.
32
  Conversely, a dephosphorylated state of eIF2α has been reported to be stimulated 
by short-term increases in extracellular glucose,
33
 and this correlates at least partially with 
increased protein synthesis in beta cells
34
 (Fig. 5).  Loss of PERK function with an exuberant 
proinsulin synthetic response, even at lower glucose levels, has been directly linked to 
proinsulin misfolding.  PERK deficiency in beta cells causes ER distention
32,35
 with 
proinsulin abnormally retained therein.
36,37
  Indeed, when pancreatic beta cells are lysed, and 
the detergent-solubilized cytoplasmic proteins are spun for 450,000 g-min onto a 20% 
glycerol cushion, proinsulin does not ordinarily penetrate the glycerol cushion.  However, 
within a few hours after beta cells are treated with a chemical inhibitor of PERK, proinsulin 
synthesis is augmented, and the proinsulin that begins to accumulate in these cells is able to 
pellet through the glycerol cushion, indicating the formation of abnormally high-molecular-
weight protein complexes.
38
  When analyzed by SDS-PAGE under nonreducing conditions, 
some of the proinsulin (molecular mass ~ 9 kDa) can be recovered in complexes up to ~100 
kDa—although the same protein is recovered at its usual expected molecular mass by SDS-
PAGE under reducing conditions.
38
  Moreover, the accumulated proinsulin that was 
synthesized at increased levels under PERK-deficient conditions is defective for anterograde 
trafficking to the Golgi complex,
39
 leading to deficient insulin production and secretion.  This 
behavior appears to explain the phenotype of patients with Wolcott-Rallison syndrome,
40
 a 
disease caused by naturally occurring loss-of-function mutations in PERK leading to neonatal 
diabetes attributable to beta cell failure
32
 as well as multiple other tissue defects.
41
 
PERK is one of four kinases that can specifically phosphorylate eIF2α at Ser51 and 
thereby negatively regulate global protein synthesis as part of the integrated stress response.
42
  
Defects in eIF2α phosphorylation can be emulated by expression of the eIF2α-S51A mutant 
that can no longer be phosphorylated at this site.  Global eIF2α-S51A heterozygous animals 
have been found to be sensitive to high-fat diet–induced diabetes with diminished insulin 
secretion accompanied by distention of the ER lumen in pancreatic beta cells (similar to that 
seen in PERK deficiency) along with increased proinsulin binding to the HSP70 family 
member of the ER (known as BiP) in conjunction with defective anterograde proinsulin 
trafficking.
43
  Global homozygous eIF2α-S51A expression (i.e., unregulated overactivity of 
the eIF2B complex) is a lethal condition
44
 that can be rescued by global expression of a wild-
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proinsulin synthesis in islet beta cells and prevents lethality.  In such animals, superimposed 
beta cell–specific expression of Cre recombinase deletes this transgene (in beta cells), 
causing proinsulin synthesis to increase in a manner that cannot be suppressed despite ER 
stress—and, once again, this leads to distention of the beta cell ER accompanied by insulin-
deficient diabetes.
45
  All of these findings suggest that excessive synthesis of proinsulin 
promotes its misfolding to a level that impairs insulin production, leading to insulin 
deficiency.  Could excessive proinsulin biosynthesis predispose to beta cell dysfunction in 
type 2 diabetes?  Using db/db mice as a model, the answer is yes, as it has recently been 
demonstrated that glucose-stimulated proinsulin biosynthesis is 14- to 15-fold increased over 
that in otherwise congenic animals lacking the db allele (basal proinsulin biosynthesis is also 
increased, as is the intracellular proinsulin-to-insulin ratio), and the increased proinsulin no 
longer exhibits a typical Golgi-like distribution pattern but rather a steady-state distribution 
suggestive of enhanced accumulation in the ER.
46
  Of course, the relevance of these findings 
to beta cell failure in human obesity–related type 2 diabetes still remains to be proven.
47
   
Curiously, in contrast with loss of PERK-mediated phosphorylation of eIF2α, 
activation of PERK-mediated phosphorylation of eIF2α, despite initial protein synthesis 
repression, can ultimately lead to downstream activation of transcription factors ATF4, 
CHOP, and GADD34, which themselves may promote a rebound increase of protein 
synthesis through enhanced amino acid uptake, tRNA synthesis, and even dephosphorylation 
of eIF2α
48–50
—these rebound conditions can also potentially add to cellular stress and protein 
misfolding.  Additionally, increased glucose stimulates the Ire1-spliced XBP pathway to 
expand ER capacity and accelerate proinsulin translation
51
 while also promoting the 





Misfolded proinsulin molecules occur in conjunction with perturbations of the ER 
folding environment   
Accumulation of misfolded proinsulin is thought to occur under conditions of molecular 
crowding within the limited ER luminal space.
53,54
  The ER luminal environment has been 
estimated to bear a protein concentration of ~ 100 mg/mL; such a concentration could not 
permit proinsulin solubility without the support of ER-resident chaperone and foldase 
activity.
55
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folding and solubility, as recombinant proinsulin expression in heterologous cell types is 
thought to fare worse than endogenous proinsulin expressed in beta cells.
56
  Nevertheless, as 
described throughout this review, beta cells remain quite susceptible to proinsulin misfolding.  
In the last decade, it has been suggested that a portion of proinsulin in beta cells may be 
recovered in non-native oligomers or aggregate, the formation of which is susceptible to 
disturbances in beta cell energy production, calcium changes, reductive stress, and 
inflammatory cytokine exposure.
57
  The relative abundance of misfolded proinsulin 
molecules, through dominant-negative behavior, further influences the success of folding of 
additional bystander proinsulin molecules.
28
  Additionally, several resident proteins have 
been found to be more abundant in the ER of glucose-responsive (compared with 
unresponsive) beta cells, including ERp29 (PDIA9), protein disulfide isomerase (PDI), BiP, 
and the HSP90 family member of the ER known as GRP94.
58
  Each of these proteins has 
been found by ER-specific proteomic analyses of pancreatic beta cells.
59
  An area of intense 
interest involves treatments that may allow beta cells to alter their ER luminal environment in 
ways that may allow for improved function in the face of increased misfolded proinsulin.  
One of the most straightforward ways to document success or failure of proinsulin 
folding to the native state is by evaluating the status of its three disulfide bonds.
15
  There is 
evidence to support the view that formation of these disulfide bonds may be catalyzed 
directly or indirectly within the ER environment.
60,61
  Peroxiredoxin-4 (PRDX4) has the 
potential to contribute to proinsulin disulfide bond formation, but ordinarily its expression 
level in pancreatic beta cells is thought to be very low.
62
  One of the main ER oxidases that 
functions upstream of ER oxidoreductases is ER oxidoreductin 1 (ERO1).  First discovered in 
yeast cells, ERO1 can receive reducing equivalents from PDI, which in turn can receive 
reducing equivalents from the cysteine thiols of substrate proteins.
63
  Pancreatic beta cells 
express two ERO1 homologs: the ubiquitously expressed ERO1α and the more narrowly 
expressed ERO1β;
64
 evidence suggests that ERO1 activity participates in proinsulin 
folding,
65,66
 and loss of ERO1β gene expression exacerbates the disease phenotype observed 
in Akita diabetic mice
65
 (as noted above, these animals express wild-type proinsulin from 
three normal alleles and misfolded proinsulin-C(A7)Y from one mutant Ins2 allele
30, 67
).   
In the oxidation chain downstream of ERO1 are a wide array of ER oxidoreductases.
68
  
Whereas PDI is the flagship member, and PDI has been found to help beta cells 
overexpressing human IAPP,
69









  Indeed, overexpression of PDI in cultured beta cells 
promotes ER accumulation of proinsulin and decreased glucose-stimulated insulin 
secretion.
71
  However, oxidized PDI may still be valuable in the ER to oxidize other 
oxidoreductases of the ER lumen; indeed, in equilibrium, one ER oxidoreductase may 
distribute its oxidation power to the other intraluminal ER catalysts of disulfide bond 
formation.
72,73
  Moreover, rather than playing a direct role in proinsulin folding, PDI may 
participate in ERAD of proinsulin
74
 in conjunction with other ER luminal components.
75
  As 
discussed further below, this could have significant indirect consequences for the folding of 
newly synthesized proinsulin in the ER of pancreatic beta cells.   
Two other major ER oxidoreductases––P5 (PDIA6) and ERp46 (PDIA15)––have 
been reported to be preferential oxidation substrates for PRDX4
73
 (which is not thought to be 
highly expressed in beta cells), yet they may have potential to promote insulin production.
76,77
  
The action of P5 (PDIA6) in beta cells might not involve a direct effect on proinsulin 
folding
78
 and might similarly be involved in proinsulin ERAD
79
 or in physiological ER stress 
signaling via interactions with IRE1.
80
  ERp44 (PDIA10) has also been suggested to be a 
proinsulin-interacting protein,
81
 but its function in proinsulin folding is unknown.  
Additionally, ERp72 (PDIA4) has been implicated indirectly in proinsulin misfolding.
82
 
ER molecular chaperones (lacking oxidoreductase activity) have also been strongly 
linked to proinsulin folding.  The ER luminal chaperone BiP is not only upregulated in 
response to beta cell ER stress, but BiP is routinely found in complexes with misfolded 
proinsulin molecules.
30,83
  Transgenic BiP overexpression in islet beta cells did not change 
islet insulin content but did protect against high-fat diet–induced diabetes, suggesting 
improvement in proinsulin folding.
84
  BiP overexpression similarly improved glucose-
stimulated insulin secretion in cultured beta cells exposed to chronic hyperglycemia.
71
  BiP 
activity to promote insulin production in beta cells is likely to be supported by helper 
proteins, such as co-chaperone ERdj4,
85
 the nucleotide exchange factor SIL1,
86
 the DnaJ 
homolog p58IPK,
87
 and GRP170 (discussed below).   
ER calcium concentration is another homeostatically regulated parameter of the ER 
luminal environment that is attuned to optimize the performance of many ER-resident 
proteins.  Cytokine activity can result in the depletion of ER luminal calcium and can activate 
ER stress
88
 that may be mediated by proinsulin misfolding—possibly because ER luminal 
calcium deficiency creates secondary deficiency in the maintenance of the ER oxidative 
environment needed for disulfide bond formation.
89
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in various tissues is driven by members of the SERCA protein family,
90
 of which SERCA2b 
is a major contributor to ER calcium as well as a contributor to the differentiated function of 
beta cells,
91,92
 which may account for the observation that thapsigargin, a pan-SERCA pump 
inhibitor, impairs proinsulin export from the ER
93
 and induces beta cell ER stress.
94
 
Other resident proteins in the beta cell ER luminal environment are less well defined 
but may also be important, including SDF2L1, which may affect the ERAD rate of misfolded 
proinsulin,
95
 as well as numerous other proteins, such as Torsin 1–3, that are present in the 
beta cell ER
59
 but remain uncharacterized outside of the nervous system.
96
   
Overall, the ER luminal microenvironment is homeostatically regulated via 
physiological ER stress-response signaling, also known as the unfolded protein response 
(UPR).  A detailed discussion of UPR signaling is beyond the scope of this review, but there 
is reason to think that each of the major ER stress–sensor proteins contributes to fine-tuning 
the composition of the proinsulin folding environment.  Adult mice lacking IRE1 in beta cells 
exhibit normal general secretory pathway morphology and normal proinsulin mRNA levels 
but decreased proinsulin synthesis, with some ER-resident protein mRNAs decreased as well 
(such as ERdj4), plus decreased ATF6 (at the mRNA level) and spliced XBP1—these are all 
genes needed for adequate beta cell biosynthetic response to glucose—and the net result is 
diminished insulin secretory granules leading to hypoinsulinemia and hyperglycemia.
51,97,98
  
Mice lacking XBP1 (downstream of IRE1) in beta cells also exhibit impaired proinsulin 
processing, decreased insulin content in beta cells, and hyperglycemia.
99
  Mice lacking ATF6 
exhibit a swollen beta cell ER, accompanied by diminished pancreatic insulin content.
100
  
And, as noted above, mice deficient for PERK in beta cells develop a swollen ER with 
accumulated proinsulin and diabetes.
32
   
 
 
Misfolded proinsulin molecules occur in conjunction with proinsulin coding sequence 
mutations  
Based on proton NMR and additional biophysical analyses, the solution structure of 
proinsulin reveals a folded insulin moiety (sharing the same three disulfide bridges as that of 
native insulin) and a largely unstructured connecting peptide, except at the cleavage 
junctions.
101
  Two of the three disulfide bonds of proinsulin are largely buried within the 
globular protein, whereas the Cys(B7)–Cys(A7) bond lies closer to the protein surface.
102
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formation of the critical Cys(B19)–Cys(A20 linkage.
15
  In mouse pancreatic islets pulsed 
with 
35
S-amino acids, within a 60-s labeling period (and no chase), a large fraction of newly 
synthesized preproinsulin molecules have completed the nascent chain, cleaved the signal 
peptide utilized for entry into the ER, and already formed all three of the native proinsulin 
disulfide bonds (Fig. 6)— thus, the native folding of proinsulin is ordinarily a very rapid 
process.
25
   
A large subset (approximately 30) of the reported INS mutations are known to trigger 
a form of diabetes known as mutant INS gene–induced diabetes of youth (MIDY);
103
 which 
masquerades as several different diabetic syndromes but is often linked to neonatal diabetes 
(first 6 months of life);  about a dozen other mutations lead to diabetes diagnosed after 6 
months (sometimes referred to as MODY-10).  Published data indicate that all of the distinct 
MIDY alleles, to greater or lesser degrees, encode a misfolded proinsulin protein.
104
  Since 
humans have only one INS gene (one paternally inherited and one maternally inherited 
allele), it is a reasonable first approximation that 50% of the proinsulin molecules synthesized 
in MIDY patients represent the misfolded mutant protein.  This fraction of misfolded 
proinsulin may be much greater than the fraction of proinsulin misfolding caused by mere 
upregulation of the synthesis of wild-type proinsulin,
22,43
 such as may exist in type 2 
diabetes.
105
  On this basis alone, it should not be surprising that, in families transmitting the 
mutant gene through the germ line, the disease is inherited as an autosomal dominant (i.e., 
expression of the heterozygous mutant allele tracks with the diabetes phenotype).
106,107
  By 
contrast, insulin haploinsufficiency is inherited as a recessive trait and thus does not, in single 
copy, cause insulin-deficient diabetes.
108
   
The mutant proinsulin proteins encoded by different MIDY alleles have been 
characterized in a variety of ways.  One method exploits the fact that the C-peptide of 
proinsulin is an unstructured domain;
101
 researchers have taken advantage of this property by 
inserting an epitope tag or even the entire green fluorescent protein (GFP) into the C-peptide, 
which allows for normal insulin production in beta cells while providing special recognition 
of the gene product from the tagged allele.
109
  It is not surprising that all of the expressed 
MIDY mutants, to varying degrees, show an increase in ER 
localization/accumulation.
31,110,111
   
Importantly, the onset of diabetes from the MIDY gene product is attributed to a gain-
of-toxic-function the results in diminished insulin production and secretion from the wild-
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Ins2 alleles, by 4 weeks of age, islet areas are normal, but insulin immunostaining of beta 
cells is markedly decreased, accompanied by a markedly expanded beta cell ER 
compartment, misfolded proinsulin associated with BiP, indications of chronic ER stress, 
decreased islet insulin secretion, and decreased insulin levels in the bloodstream.
30,67,112
  The 
initial decreased islet insulin production occurs because the misfolded proinsulin engages 
directly in protein complexes with bystander proinsulin molecules, impairing the egress of 
wild-type proinsulin from the ER and thereby blocking wild-type insulin production.
31
   
Eventually, stress in the secretory pathway gives way to progressive perturbation of 
organelle architecture
113
 and beta cell death.
114
  Although these may be secondary events, 
they are no less important; indeed it might be possible to circumvent or suppress some of 
these secondary phenotypes
87,114–121
 even without relief from the primary problem (dominant-
negative suppression of wild-type proinsulin anterograde export from the ER).  One example 
of such secondary suppression may be achieved by lowering the body’s need for pancreatic 
insulin by agents that help to lower blood glucose,
122,123
 including exogenous insulin.
124,125
  
Another pharmacologic approach may be to develop compounds that could attenuate 
proinsulin oligomerization
126,127
 and thereby limit dominant-negative effects of misfolded 
proinsulin on bystander proinsulin molecules.   
 
 
Misfolded proinsulin clearance  
Two main mechanisms of clearance of misfolded proinsulin molecules are ERAD and 
autophagy.  The principles underlying ERAD involve recognition of misfolded proteins, 
targeting such proteins to the ERAD complex, retrotranslocation across the ER membrane, 
ubiquitylation of target proteins, extraction of ubiquitylated target proteins from the cytosolic 
face of the ER membrane, and degradation by 26S proteasomes.
128
  The two core molecules 
of the ERAD machinery are the partner proteins HRD1 and SEL1/HRD3, which are 
conserved even in yeast.
129
  The polytopic HRD1 membrane protein functions in both 
retrotranslocation and as an E3 ubiquitin ligase, whereas the single membrane–spanning 
SEL1 physically associates with HRD1 and is required for HRD1 protein stability, while also 
helping to present ERAD substrates to HRD1; many other ancillary proteins interact with the 
core complex, and these topics are reviewed in detail elsewhere.
130
  The ERAD core complex 
is upregulated by the ER stress response,
36,131
 suggesting that one of its key functions is to 
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pathway carrying proinsulin is a likely trigger for enhanced proinsulin ERAD.
132
 
There is strong reason to believe that misfolded proinsulin is an ERAD substrate.  
First, as noted above, islet beta cells that have misfolded proinsulin exhibit upregulated 
expression of HRD1 and SEL1/HRD3.
133,134
  Second, treatment of beta cells with a variety of 
perturbants that poison the ER folding environment has been found to increase both 
proinsulin misfolding and proinsulin disappearance by pulse-chase analysis.
57,135
  Third, 
many MIDY mutant proinsulins have been shown to be degraded, at least in part, via 
proteasomal disposal mechanisms.
104
  Fourth, short hairpin RNA (shRNA)-mediated 
knockdown of HRD1 and the p97 ATPase (involved in ER extraction of ubiquitylated 
proteins for proteasomal disposal) were both reported to increase steady-state levels of 
proinsulin in beta cells.
136
   
Recent studies of the proinsulin-C(A7)Y mutant, which causes diabetes in the Akita 
mouse, have confirmed that the misfolded proinsulin utilizes the HRD1–SEL1L core ERAD 
complex and further requires p97 for its proteasomal degradation.
74
  Intriguingly, PDI was 
also found to engage the misfolded mutant proinsulin, and the absence of PDI activity 
triggered enhanced proinsulin aggregation into aberrant disulfide-bonded proinsulin 
complexes, clarifying one of the upstream elements involved in recognition or targeting 
misfolded proinsulin to the ERAD core complex.
74
  Additional work has revealed that the ER 
chaperone GRP170 also acts in the upstream ERAD pathway of misfolded proinsulin in such 
a way as to decrease the abundance of high-molecular-weight proinsulin aggregates, 
promoting smaller proinsulin complexes that have better competence for retrotranslocation 
and proteasomal disposal.
75
  Interestingly, GRP170 is particularly highly expressed in islet 
beta cells, and its expression seems to parallel that of proinsulin.
137
  Most remarkable, in cells 
expressing both wild-type proinsulin and the proinsulin-C(A7)Y mutant, GRP170 
overexpression assisted in the selective degradation of the mutant, liberating the wild-type 
proinsulin for export from the ER and production of native insulin.
75
  This is of obvious 
potential interest in limiting proinsulin aggregation in order to improve beta cell function for 
the prevention of diabetes.   
There is also reason to suspect that ER-phagy may be an important pathway of 
misfolded proinsulin disposal.
7
  First, proinsulin misfolding has been observed to stimulate 
autophagy.
117
  Second, mice with beta cell-specific deletion of the ATG7 autophagy gene 
showed accumulation of intracellular ubiquitinated protein aggregates and ER distention 
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cell mass leading to hyperglycemia.
138
  Third, treatment of female Akita mice with rapamycin 
(an mTOR inhibitor), which stimulated autophagosome formation and autophagic flux in beta 
cells, also increased pancreatic insulin content and decreased measures of beta cell ER 
stress.
139
  However, proinsulin that has undergone anterograde trafficking beyond the ER may 
also reach autophagosomes, and such molecules are unlikely to be misfolded.
140
   
 
 
Clinical implications  
Type 2 diabetes is the most common form of diabetes mellitus worldwide, and it is still 
debated whether stimulating beta cell insulin secretion or providing beta cell rest is the 
optimum therapy for the disease.
141
  Before onset of disease, beta cells increase their insulin 
production in response to increased demand driven by insulin resistance.  Under states of 
pancreatic insulin depletion, increasingly active beta cell exocytosis is also accompanied by 
hyperproinsulinemia,
142,143
 which decreases available substrate for conversion to insulin and 
adds more pressure on beta cells to increase active hormone production through proinsulin 
biosynthesis.  Exposure to cytokines
144,145
 and environmental toxins
146
 could further 
exacerbate this problem (Fig. 7).  Both hyperlipidemia and hyperglycemia may initially 
promote more proinsulin biosynthesis, but they ultimately trigger severe beta cell ER 
stress.
147
   
It is generally recognized that type 2 diabetes does not develop until there is a 
significant deficiency of insulin secretion.
148
  While the initiating/inciting origin of this 
common insulin secretory defect remains obscure in garden-variety type 2 diabetes, evidence 
from rare (monogenic) forms of diabetes are shedding light on basic processes essential for 
healthy insulin production.  Indeed, even as complex diseases, such as diabetes, have a 
multifactorial etiology (including both genetic and environmental predisposition), a number 
of rare forms of diabetes exhibiting Mendelian inheritance (including autosomal dominant 
inheritance) may provide highly fruitful clues to the intracellular organelles and pathways 
that are most susceptible to breakdown in beta cell dysfunction.  Some of these rare diseases 
include Wolfram syndrome,
149





 which, as noted above, causes loss 





 which is a direct cause of proinsulin misfolding in the ER and insulin-deficient 
diabetes.
7
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In garden-variety type 2 diabetes, it is increasingly recognized that genetic 
perturbation of islet regulatory elements can alter islet transcriptional responses to ER 
stress,
155
 to which beta cells are highly susceptible.
156
  Genome-wide association studies may 
also suggest that allelic variants encoding proteins involved in ER-related processes can 
confer increased type 2 diabetes susceptibility.
157
  Indeed, islet beta cells from human type 2 
diabetes patients have an increased ER volume density that is plausibly consistent with 
increased proinsulin synthesis; at the same time, isolated islets from type 2 diabetic 
individuals exhibit decreased insulin secretion, and these islets exhibit a more easily induced 
ER stress response to hyperglycemic conditions.
158
   
Increased proinsulin production in type 2 diabetes accompanied by decreased 
intrapancreatic insulin stores is also present in animal models.
159
  There is increasing 
evidence of islet beta cells with vigorously active ongoing proinsulin biosynthesis that are 
nevertheless insulin deficient (by immunofluorescence).
46
  There is also evidence that 
attenuating beta cell proinsulin synthesis can improve proinsulin maturation, insulin 
production, and insulin secretion in vivo
124
 and in vitro.
46
  However, additional work is still 
needed to establish a direct link between proinsulin misfolding and pancreatic beta cell 
failure in human type 2 diabetes and to develop therapies to limit accumulation of misfolded 
proinsulin.
66,75
   
In this review, we highlighted features that promote proinsulin misfolding, including 
its increased synthesis, altered ER environment, the presence of proinsulin structural defects, 
and deficiency of clearance of misfolded proinsulin.  We propose that these processes are 
fertile areas for studies of molecular and cellular mechanisms that may predispose to beta cell 
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Figure 1.  Pattern of disulfide bond formation throughout the insulin/IGF superfamily.  (A) 
Reproduced from Ref. 19, with permission from the publisher.  (B) The human insulin 
peptide sequence is inserted into the disulfide pattern shown in panel A.  The first two Cys 
residues fall within the insulin B-chain (in red), and the remaining four Cys residues fall 
within the insulin A-chain (in blue).  The conversion of the single-chain proinsulin to the two-
chain insulin molecule involves excision of the connecting C-peptide (shown in orange) via 
endoproteolytic cleavage followed by carboxypeptidase cleavage at dibasic sites (green 









Figure 2.  Non-native isomer of newly synthesized proinsulin shows enhanced binding to the 
ER HSP70 chaperone BiP.  Fifty isolated rat pancreatic islets were pulse labeled with 
35
S-
labeled amino acids and then lysed immediately and either immunoprecipitated with a 
polyclonal antibody to insulin that recognizes all proinsulin forms or co-immunoprecipitated 
with anti-BiP.  The immunoprecipitates were analyzed by nonreducing Tris–Tricine–urea–
SDS-PAGE.  In addition to native disulfide-bonded proinsulin, a more slowly migrating 
proinsulin disulfide isomer is preferentially associated with BiP.  Reproduced from Ref. 15 
with permission from the publisher.  
 
Figure 3.  Protein interactions of proinsulin-C(A7)Y.  (A) The INS1 pancreatic beta cell line 
was used, either untransfected (control) or transfected to express hPro-CpepGFP or 
hProC(A7)Y-CpepGFP (the latter bearing the Akita proinsulin mutation).  Cell lysates were 
subjected to western blotting with anti-GFP after SDS-PAGE under reduced or nonreduced 
conditions.  Not only is hProC(A7)Y-CpepGFP not endoproteolytically processed in beta 
cells, but the protein is recovered in higher-molecular-mass protein complexes (open arrows) 
that are detected only under nonreduced conditions. (B) The same cells from panel A were 
pulse labeled with 
35
S-labeled amino acids for 30 min and lysed, then GFP-containing 
peptides were immunoprecipitated, and the samples were analyzed by Tris–tricine–urea–
SDS-PAGE under reducing conditions to detect coimmunoprecipitation of endogenous 









Figure 4.  Steps contributing to proinsulin aggregation in the ER folding environment.  
Upper panel: under healthy conditions, proinsulin synthesis is limited to physiological levels 
(small font) and folds within a generally favorable folding environment leading to successful 
export from the ER (thick green arrow).  The misfolded proinsulin that is generated in 
parallel with native folding is actively disposed of, including monomer disposal (thick brown 
arrow) and aggregate disposal (thick blue arrow).  Through each of these mechanisms, the 
steady-state level of misfolded proinsulin is held to low levels.  Lower panel: under unhealthy 
conditions, proinsulin synthesis is exuberant to a level that may be considered 
supraphysiological; the increased supply of unfolded monomers leads to the production of 
more proinsulin aggregates, exceeding the disposal of misfolded proinsulin, such that the 








Figure 5.  Glucose-related changes in eIF2 phosphorylation in MIN6 cells.  MIN6 cells (i.e., 
cells of a mouse pancreatic beta cell line) were preincubated in no glucose (1 h) before 
incubation in the indicated concentrations of glucose for 1 h in the presence of 
[
35
S]methionine.  Upper panel: cell lysates were analyzed by SDS-PAGE and western 
blotting with anti-phospho-eIF2α (P-eIF2α) and anti-eIF2α. Lower panel: incorporation of 
[
35
S]methionine into total protein, as a percent of control (0 mm glucose).  Adapted from Ref. 
27 with permission from the publisher.   
 
Figure 6.  Rapid formation of native proinsulin disulfide bonds.  Isolated mouse pancreatic 
islets were pulse labeled for 60 s with 
35
S-labeled amino acids and either lysed without chase 
or chased in the presence of cycloheximide (100 µg/mL) to prevent further proinsulin 
synthesis.  The islets were lysed and analyzed by Tris–-tricine–urea–SDS-PAGE and 
phosphorimaging; the position of oxidized native proinsulin is shown.  Reproduced from Ref. 
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Figure 7.  Hypothesis: relevance of proinsulin misfolding to insulin deficiency/beta cell 
dysfunction in garden-variety diabetes mellitus.   This figure has been adapted and altered 
from Fig. 1 of Ref. 47; permission from publisher is pending.   
 
 
 
